Gestational diabetes poses risks to both mother and child during pregnancy. Probiotics, beneficial bacteria that promote gut health, have emerged as a potential ally in managing this condition. Studies suggest that certain strains of probiotics, such as Lactobacillus and Bifidobacterium, may help regulate blood sugar levels and reduce inflammation, factors relevant to gestational diabetes. Moreover, prebiotics, indigestible fibers that nourish these beneficial bacteria, play a crucial role. Combining probiotics with prebiotics in the form of dietary supplements or foods like yogurt and kefir can foster a healthy gut microbiome, potentially improving glucose metabolism and insulin sensitivity. However, further research is needed to determine the optimal strains, dosage, and timing of probiotic intervention for managing gestational diabetes effectively.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India